Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model
) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole was unchanged today. By the end of trading, C.R. Bard fell $2.45 (-2.5%) to $96.25 on heavy volume. Throughout the day, 1.2 million shares of C.R. Bard exchanged hands as compared to its average daily volume of 513,300 shares. The stock ranged in price between $95.74-$98.38 after having opened the day at $96.97 as compared to the previous trading day's close of $98.70. Other companies within the Health Services industry that declined today were:
), down 10%,
), down 7.2%,
), down 5.8%, and
), down 5.8%.
- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
C. R. Bard, Inc. and its subsidiaries design, manufacture, package, distribute, and sell medical, surgical, diagnostic, and patient care devices worldwide. C.R. Bard has a market cap of $8.26 billion and is part of the health care sector. The company has a P/E ratio of 16.7, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7. Shares are up 15.4% year to date as of the close of trading on Tuesday. Currently there are three analysts that rate C.R. Bard a buy, one analyst rates it a sell, and 11 rate it a hold.
TheStreet Ratings rates C.R. Bard as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in stock price during the past year, notable return on equity, compelling growth in net income and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow.
- You can view the full C.R. Bard Ratings Report.
On the positive front,
), up 26.3%,
), up 13.6%,
), up 12.8%, and
), up 7.6%, were all gainers within the health services industry with
) being today's featured health services industry leader.
- Use our health services section to find industry-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider
) while those bearish on the health services industry could consider
- Find other investment ideas from our top rated ETFs lists.
FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge!
Free download now